Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer

January 22, 2023

https://www.globenewswire.com/news-release/2023/01/20/2592732/0/en/Journey-Medical-Corporation-Appoints-Joseph-Benesch-as-Interim-Chief-Financial-Officer.html

SCOTTSDALE, Ariz., Jan. 20, 2023 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq:DERM) (“Journey Medical” or the “Company”), a commercial-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced that Ernest (Ernie) De Paolantonio has notified the Company that, effective January 27, 2023, he will step down as Chief Financial Officer of Journey Medical to pursue another opportunity. The Company also today announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023.

Read more at globenewswire.com

Related news for (DERM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.